Clearmind Medicine Announces Institutional Review Board Approval For FDA Clinical Trial Of CMND-100 At Second Clinical Site In Alcohol Use Disorder
Clearmind Medicine Announces Institutional Review Board Approval For FDA Clinical Trial Of CMND-100 At Second Clinical Site In Alcohol Use Disorder
Clearmind Medicine宣布已获得机构审查委员会批准,在酒精滥用障碍的第二个临床试验站点进行CMND-100的FDA临床试验
Clearmind Medicine Announces Institutional Review Board Approval For FDA Clinical Trial Of CMND-100 At Second Clinical Site In Alcohol Use Disorder
Clearmind Medicine宣布CMND-100在第二临床试验点获得FDA对酒精滥用障碍的临床试验机构审查委员会批准